Inpharmatica Licenses ADME Tools to Serono | GenomeWeb

Inpharmatica Licenses ADME Tools to Serono

Feb 21, 2005

NEW YORK, Feb. 21 (GenomeWeb News) - Inpharmatica said today that it has licensed its Admensa Interactive suite of predictive drug absorption, distribution, metabolism, and excretion models and compound prioritization tools to biotech firm Serono.

Under the terms of the non-exclusive deal, Serono will receive a multi-site license to the Admensa technology, as well as training and ADME consulting. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Concerns About Bias in Policies

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Reprogrammable DNA

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Lack of Diversity

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

This Week in Science

In Science this week: whole-genome sequencing of single sperm cells, and more.